IFPMA, H3D sign partnership for increased research, development of medicines in Africa

INTERNATIONAL Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and H3D Foundation have announced a new three-year phase of their partnership, aiming to boost the skills and capacity needed to drive increased research and development of new medicines in Africa. The partnership is aimed at boosting kills needed to drive drug discovery and development on the continent. IFPMA communications manager Micaela Neumann said since 2021, IFPMA and H3D Foundation have collaborated to provide early and mid-career scientists in Africa with new opportunities to develop their skills to help address this challenge. “Despite 20 percent of the global burden of disease impacting people living in Africa, just two percent of medical research focused on new infections originates in Africa,” principal investigator for Drug Innovation Group at the University of Ghana Richard Amewu said. He said the IFPMA’s partnership with H3D Foundation has lent credibility to the contine...